Dissolution specification for generic oral immediate release products - Scientific guideline

HumanVeterinaryScientific guidelines

Estonian is available via eTranslation, the European Commission's machine translation service.

Translate to Estonian | Important information about machine translation

This document discusses the suitability of the dissolution method and the specifications for in vitro dissolution of orally administered generic drug products with immediate release characteristics.

Keywords: Dissolution specification, generic, oral immediate release product

Current version

Reflection paper on the dissolution specification for generic solid oral immediate release products with systemic action - First version

Reference Number: EMA/CHMP/CVMP/QWP/336031/2017

English (EN) (156.9 KB - PDF)

Esmakordselt avaldatud: Viimati ajakohastatud:
Vaata

Document history - First version (current)

Reflection paper on the dissolution specification for generic solid oral immediate release products with systemic action - First version

Reference Number: EMA/CHMP/CVMP/QWP/336031/2017

English (EN) (156.9 KB - PDF)

Esmakordselt avaldatud: Viimati ajakohastatud:
Vaata

Overview of comments received on 'Draft reflection paper on the dissolution specification for generic solid oral immediate release products with systemic action' - First version

Reference Number: EMA/CHMP/CVMP/QWP/257305/2017

English (EN) (751.96 KB - PDF)

Esmakordselt avaldatud: Viimati ajakohastatud:
Vaata

Draft reflection paper on the dissolution specification for generic oral immediate release products - First version

Draft: consultation closed Consultation dates: to Reference Number: EMA/CHMP/CVMP/QWP/37330/2016 Summary:

This document discusses the suitability of the dissolution method and the specifications for in vitro dissolution of orally administered generic drug products with immediate release characteristics.

English (EN) (146.32 KB - PDF)

Esmakordselt avaldatud: Viimati ajakohastatud:
Vaata

Share this page